ConductScience.org, home

Paper11856477

Chemoprevention of N-methylnitrosourea-induced colon carcinogenesis by ursodeoxycholic acid-5-aminosalicylic acid conjugate in F344 rats.

Narisawa T and 3 others. Jpn J Cancer Res, 2002. Cited by 15 papers, by iCite.

Cite this record

ConductScience Library. Chemoprevention of N-methylnitrosourea-induced colon carcinogenesis by ursodeoxycholic acid-5-aminosalicylic acid conjugate in F344 rats. Papers, record 11856477. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/11856477

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Chemoprevention of N-methylnitrosourea-induced colon carcinogenesis by ursodeoxycholic acid-5-aminosalicylic acid conjugate in F344 rats.
PubMed
Journal
Jpn J Cancer Res
PubMed
Year
2002
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
15
iCite
Relative citation ratio, by iCite
0.38
iCite
Revised in PubMed
2023-11-12
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Narisawa TTomio
2Fukaura YYoko
3Takeba NNaomi
4Nakai KKeiko

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anticarcinogenic AgentsMajor topic
Colonic NeoplasmsMajor topic
MesalamineMajor topic
Ursodeoxycholic AcidMajor topic
Animals
Bile Acids and Salts
Female
Methylnitrosourea
Precancerous Conditions
Rats
Rats, Inbred F344

Source PubMed

Download CSV of topics

References30

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1884672Promoting effect of bile acids in colon carcinogenesis in germ-free and conventional F344 rats.Cancer Res1977https://conductscience.org/library/papers/884672PubMed
221559694Aspirin and other nonsteroidal antiinflammatory drugs and colorectal neoplasia.Int J Oncol1994https://conductscience.org/library/papers/21559694PubMed
34427390Promoting effect of bile acids on colon carcinogenesis after intrarectal instillation of N-methyl-N'-nitro-N-nitrosoguanidine in rats.J Natl Cancer Inst1974https://conductscience.org/library/papers/4427390PubMed
49717724Synthesis and intestinal metabolism of ursodeoxycholic acid conjugate with an antiinflammatory agent, 5-aminosalicylic acid.J Lipid Res1998https://conductscience.org/library/papers/9717724PubMed
57600544Role of aberrant crypt foci in understanding the pathogenesis of colon cancer.Cancer Lett1995https://conductscience.org/library/papers/7600544PubMed
62883067Actions of sulfasalazine and 5-aminosalicylic acid as reactive oxygen scavengers in the suppression of bile acid-induced increases in colonic epithelial cell loss and proliferative activity.Gastroenterology1987https://conductscience.org/library/papers/2883067PubMed
710464717Inhibitory effects of ursodeoxycholic acid on N-methylnitrosourea-induced colon carcinogenesis and colonic mucosal telomerase activity in F344 rats.J Exp Clin Cancer Res1999https://conductscience.org/library/papers/10464717PubMed
86928243Effect of cholic acid feeding on N-methyl-N-nitrosourea-induced colon tumors and cell kinetics in rats.J Natl Cancer Inst1980https://conductscience.org/library/papers/6928243PubMed
99849578Prevention of N-methylnitrosourea-induced colon tumorigenesis by ursodeoxycholic acid in F344 rats.Jpn J Cancer Res1998https://conductscience.org/library/papers/9849578PubMed
109687967Modulation of colonic xenobiotic metabolizing enzymes by feeding bile acids: comparative effects of cholic, deoxycholic, lithocholic and ursodeoxycholic acids.Food Chem Toxicol1998https://conductscience.org/library/papers/9687967PubMed
11573627Effects of dietary administration of chenodeoxycholic acid on N-methyl-N-nitrosourea-induced colon cancer in rats.Biochim Biophys Acta1979https://conductscience.org/library/papers/573627PubMed
127923119Chemoprevention of azoxymethane-induced colonic carcinogenesis by supplemental dietary ursodeoxycholic acid.Cancer Res1994https://conductscience.org/library/papers/7923119PubMed
138472385High performance liquid chromatographic determination of free and conjugated bile acids in serum, liver biopsies, bile, gastric juice and feces by fluorescence labeling.Clin Chim Acta1993https://conductscience.org/library/papers/8472385PubMed
142576350Sulfasalazine alters the character of dimethylhydrazine-induced colorectal carcinoma in rats.Anticancer Res1989https://conductscience.org/library/papers/2576350PubMed
159563483Enrichment of the more hydrophilic bile acid ursodeoxycholic acid in the fecal water-soluble fraction after feeding to rats with colon polyps.Cancer Res1998https://conductscience.org/library/papers/9563483PubMed
161650501Causes, relevant mechanisms, and prevention of large bowel cancer.Semin Oncol1991https://conductscience.org/library/papers/1650501PubMed
171358165The effect of therapeutic drugs used in inflammatory bowel disease on the incidence and growth of colonic cancer in the dimethylhydrazine rat model.Br J Cancer1992https://conductscience.org/library/papers/1358165PubMed
187585585Mechanism of action of chemoprotective ursodeoxycholate in the azoxymethane model of rat colonic carcinogenesis: potential roles of protein kinase C-alpha, -beta II, and -zeta.Cancer Res1995https://conductscience.org/library/papers/7585585PubMed
197912678Risk factors for colorectal cancer in patients with ulcerative colitis: a case-control study.Gastroenterology1994https://conductscience.org/library/papers/7912678PubMed
209145212Basic studies on 5-(7-hydroxy-3-O-phosphonocholyl)aminosalicylic acid for the evaluation of microbial overgrowth.Biol Pharm Bull1997https://conductscience.org/library/papers/9145212PubMed

See all 30 referencesDownload CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.

PMIDTitleJournalYearIn PapersSource
36830173Diagnosis by Microbial Culture, Breath Tests and Urinary Excretion Tests, and Treatments of Small Intestinal Bacterial Overgrowth.Antibiotics (Basel)2023https://conductscience.org/library/papers/36830173PubMed
36213655Cholecystectomy promotes the development of colorectal cancer by the alternation of bile acid metabolism and the gut microbiota.Front Med (Lausanne)2022https://conductscience.org/library/papers/36213655PubMed
359136415-Aminosalicylic acid ameliorates dextran sulfate sodium-induced colitis in mice by modulating gut microbiota and bile acid metabolism.Cell Mol Life Sci2022https://conductscience.org/library/papers/35913641PubMed
33916402Animal Models of Colorectal Cancer: From Spontaneous to Genetically Engineered Models and Their Applications.Vet Sci2021https://conductscience.org/library/papers/33916402PubMed
156377335-aminosalicylic acid is an attractive candidate agent for chemoprevention of colon cancer in patients with inflammatory bowel disease.World J Gastroenterol2005https://conductscience.org/library/papers/15637733PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/11856477

GET https://conductscience.org/api/papers/v1/11856477/references?page=2